Back

Annenberg Center for Health Sciences at Eisenhower

  • Antibodies
  • Respiratory Syncytial Virus Infections
  • Vaccination

Improving knowledge and Awareness of Preventive Antibodies for Respiratory Syncytial Virus (RSV) for Infants and Young Children

Respiratory syncytial virus (RSV) is a contagious infection of the respiratory tract and one of the most common causes of illness amongst children. Prevention is a key public health goal, either through pregnant parent vaccination or RSV antibodies. This activity consists of five (5) paired conversations with experts in nursing, pediatrics, and neonatology. During these conversations, the faculty explore the basics of RSV infection and illness, currently available immunoprophylaxis strategies, and tools to assist clinicians in preventing RSV among infants and young children. In particular, the activity provides in-depth discussion of RSV antibodies, detailing clinical evidence and recommendations to support their benefits and use.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Feb 17, 2026
  • Last day to claim credit
    Feb 18, 2027 4 months left